CollPlant Biotechnologies Ltd (CLGN)
Nasdaq: CLGN · Orthopedic, Prosthetic & Surgical Appliances & Supplies · Rehovot, IL · filing with the SEC since 2015
Who owns CollPlant Biotechnologies Ltd
As filed with the SECHolders of 5% or more
2
The Loewenbaum 1992 Trust holds 17.5% of Ordinary Shares, par value NIS 1.5 per share, as its SCHEDULE 13D/A filed Aug 21, 2026 says.
Directors and officers
11
report now, of 11 people on the record since 2026. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 2 named at left.
Holders of 5% or moreshare of the class, as filed
The Loewenbaum 1992 Trust
SCHEDULE 13D/A · filed Aug 21, 2026 · Ordinary Shares, par value NIS 1.5 per share · 25% in Jul 31, 2026
Ami Sagy
SCHEDULE 13G · filed Oct 8, 2026 · Ordinary Shares, no par value (including Ordinary Shares represented by American Depositary Shares at a 1-to-1 ratio) · 5.7% in Oct 8, 2026
What CLGN reports owning in othersstakes of 5% or more, and other ties
CollPlant Biotechnologies Ltd reports no stake in another company in the record.
Insider tradesForm 4
0sales
0purchases
0sales on a scheduled plan
0people selling
$0sold, in dollars
$0bought, in dollars
Open-market trades on Form 4 from Sep 30, 2025 to Sep 30, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
No open-market trade is on the record for these years.
Dollars as filed, summed by the transaction date.
People who traded in the window
No one on the roster filed an open-market trade in the window.